PCRX 14.65 (+2.09%)
US6951271005Drug ManufacturersDrug Manufacturers - Specialty & Generic

Pacira BioSciences (PCRX) Stock Highlights

14.65 | +2.09%
2024-09-19 04:09:20
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.

Statistics

Range Today
14.11 15.22
Volume Today 953K
Range 1 Year
11.16 35.95
Volume 1 Year 198.23M
Range 3 Year
11.16 82.16
Volume 3 Year 452.31M
Range 10 Year
11.16 121.95
Volume 10 Year 1.69B

Highlights

Market Capitalization 604.72M (small)
Floating Shares 45.63M
Current Price 14.65
Price To Earnings 9.6
Price To Revenue 1.21
Price To Book 0.69
Earnings Per Share 1.34
Payout Ratio 0%

Performance

Latest +2.09%
1 Month +11.24%
3 Months -46.3%
6 Months -50.2%
1 Year -56.82%
3 Years -73.46%
5 Years -61.41%
10 Years -85.88%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.